| Financial Year |
March 31 2023 |
| Monetary Funds |
2,961,623,157.54 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
125,577,699.60 |
| Accounts Receivable |
2,459,757,272.69 |
| Advances to Suppliers |
1,039,960,004.87 |
| Other Receivables |
527,094,309.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
45,666,666.66 |
| Dividend Receivable |
104,398,915.14 |
| Inventories |
746,769,019.54 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
167,819.75 |
| Other Current Assets |
458,959,737.61 |
| Total Current Assets |
8,462,405,036.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,204,279,792.24 |
| Investment Properties |
6,423,447.86 |
| Fixed Assetes |
18,632,773,559.03 |
| Under-construction Projects |
3,163,844,123.42 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,555,447,635.69 |
| R&D expenses |
47,136,272.92 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
20,314,495.20 |
| Deferred Income Tax Assets |
535,463,518.04 |
| Other Non-Current Assets |
364,473,665.97 |
| Sub-Total of Non-Current Assets |
30,901,022,372.87 |
| Total Assets |
39,363,427,409.37 |
| Short-Term Loans |
2,820,572,908.23 |
| Trading Financial liabilities |
-- |
| Notes Payable |
65,730,626.98 |
| Accounts Payable |
2,209,193,518.87 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
89,734,882.82 |
| Taxes Payable |
66,531,451.01 |
| Interest Payable |
-- |
| Dividend Payable |
13,172,125.16 |
| Other payables |
619,046,946.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
836,228,022.21 |
| Other Current Liabilities |
45,925,492.62 |
| Sub-Total of Current Liabilities |
6,964,124,926.63 |
| Long-term Loans |
16,017,727,700.34 |
| Bonds Payable |
2,500,000,000.00 |
| Long-Term Accounts Payable |
9,903,819.40 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
15,386,162.42 |
| Other Non-Current Liabilities |
10,039,291.53 |
| Sub-Total of Non-Current Liabilities |
20,177,747,675.77 |
| Total Liabilities |
27,141,872,602.40 |
| Paid-In Capital(Or Share Stock) |
1,791,626,376.00 |
| Capital Surplus |
4,451,335,815.87 |
| Surplus Reserve |
839,391,457.87 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,532,448,707.81 |
| Minority Stockholder's Interest |
2,583,683,688.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,637,871,118.35 |
| Owner's Equity（Stockholder's Equity） |
12,221,554,806.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
39,363,427,409.37 |
